Kellie Newsome, PMHNP

Psychiatrist Chris Aiken, MD, and Psychiatric Nurse Practitioner Kellie Newsome discuss the generic form of Vilazodone, exploring its efficacy in managing depression and anxiety disorders, its impact on treating anxious depression, and its tolerability compared to SSRIs. They highlight the importance of understanding the drug's mechanism of action, onset of action, and remission rates from trials and studies.

Beverly Stoute, MD, a medical doctor focused on racial and social biases in psychoanalysis, joins Kellie Newsome, PMHNP, to delve into critical issues. They discuss systemic racism in psychoanalytic training heightened by recent societal events. The conversation addresses the struggles BIPOC candidates face, including financial obstacles and inadequate support. Stoute emphasizes the importance of cultural sensitivity in treatment, urging for updated training practices to foster inclusivity and better support for diverse patients in psychoanalysis.

Psychiatrist Chris Aiken and PMHNP Kellie Newsome discuss the recent FDA rejection of MDMA therapy for PTSD, exploring issues like boundary violations and functional unblinding. They analyze biases in medication trials, potential risks of MDMA, and the advocacy for its medical use in treating PTSD. The podcast also explores cardiovascular risks of MDMA, therapist influence on patient outcomes, and the need for standardized evaluation methods.